Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomasM Kelly Nicholas, Rimas V Lukas, Nazia F Jafri, et al.Cancer Biology & Therapy|March 15, 2008
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypesShahid S Siddiqui, Sivakumar Loganathan, Soundararajan Krishnaswamy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancerJohn D Hainsworth, Liang Fang, Jane E Huang, et al.Clinical Lung Cancer|November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trialEzra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.Anti-Cancer Drugs|September 4, 2008
Protein kinase C beta in malignant pleural mesotheliomaLeonardo Faoro, Sivakumar Loganathan, Maria Westerhoff, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 14, 2009
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcriptionRajani Kanteti, Vidya Nallasura, Sivakumar Loganathan, et al.Gynecologic Oncology|April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trialDavid R Spigel, Peter M Townley, David M Waterhouse, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid TumorsNiharika B Mettu, Susanna V Ulahannan, Johanna C Bendell, et al.Journal of Visualized Experiments : Jove|February 10, 2011
Generation of comprehensive thoracic oncology database--tool for translational researchMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.Pageof 2